PADMA Lax cpr 60 pce

7680358720947 CH-35872 A06AB20 20.03.2.
PADMA Lax cpr 60 pce
PADMA Lax cpr 60 pce
PADMA Lax cpr 60 pce
1 / 3
google

Details

Product number
3587202
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
aloes extractum siccum normatum (Aloe ferox Mill., Aloe barbadensis Mill., folii succus siccatus) 12.5 mg corresp. glycosida anthrachinoni 2.4-2.6 mg, Auszugsmittel aqua, kaolinum ponderosum 25 mg, calumbae radicis pulvis (Jateorhiza palmata (Lam.) Miers., radix) 10 mg, condurango corticis pulvis (Marsdenia reichenbachii Triana, cortex) 10 mg, helenii rhizomatis pulvis (Inula helenium L., rhizoma) 35 mg, gentianae radicis pulvis (Gentiana lutea L., radix) 35 mg, myrobalani fructus pulvis (Terminalia chebula Retz., fructus) 35 mg, natrii hydrogenocarbonas 15 mg, natrii sulfas anhydricus 35 mg, piperis longi fructus pulvis (Piper longum L.,Piper retrofractum Vahl, fructus) 3.5 mg, frangulae corticis pulvis (Frangula alnus Mill., cortex) 52.5 mg, rhamni purshianae corticis pulvis (Rhamnus purshiana DC., cortex) 52.5 mg, rhei radicis pulvis (Rheum officinale Baill., Rheum palmatum L., radix) 70 mg, strychni seminis pulvis (Strychnos nux-vomica L., semen) 1.75 mg, zingiberis rhizomatis pulvis (Zingiber officinale Roscoe, rhizoma) 70 mg, glucosum liquidum 20 mg, calcii stearas, saccharum 3.8-5.6 mg, pro compresso.

Articles (1)

Padma Lax, Tabletten
Tabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/11/2023
Professional SmPC
Français
16/11/2023
Professional SmPC
Italien
16/11/2023
Patient information leaflet
Allemand
14/11/2023
Patient information leaflet
Français
14/11/2023
Patient information leaflet
Italien
14/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIIS
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
15.0 MG Substance Wirkstoff (Principe actif)
(N/A)
35.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.5 MG Substance Wirkstoff (Principe actif)
(N/A)
52.5 MG Substance Wirkstoff (Principe actif)
(N/A)
52.5 MG Substance Wirkstoff (Principe actif)
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.75 MG Substance Wirkstoff (Principe actif)
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

PADMA AG

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
35872
Drug name
Padma Lax, Tabletten
Galenic form
TAB
ATC Code
A06AB20
Authorization status
Z
Dispensation category
B/D
First authorization
17/11/1970
Authorization expiration date
31/12/9999
IT number
20.03.2.
Domain
Human medicine
Field of application
Nach den Therapieprinzipien der Tibetischen Medizin bei Verstopfung

Packaging details

Description (FR)
PADMA Lax cpr 60 pce
Description (DE)
PADMA Lax Tabl 60 Stk
Market launch
30/10/1996
Narcotic (BTM)
No

Other packaging sizes

PADMA Lax cpr 20 pce
20 TABL
View